Patents by Inventor Berend SNIJDER

Berend SNIJDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230086120
    Abstract: The invention relates to peripheral blood mononuclear cell (PBMC) monolayers or bone-marrow cell monolayers and methods for its culture and corresponding uses of said monolayers. The present invention also relates, in some aspects, to screening methods comprising the PBMC monolayer or bone-marrow cell monolayer of the invention for determination of response or lack of response of a disease to a therapeutic agent and/or drug screening methods. In some aspects, the invention further relates to methods for diagnosing a disease or predisposition to a disease in a PBMC donor or bone-marrow cell donor comprising the PBMCs/bone-marrow cells cultured according to the method of the invention and/or to methods for determining whether the disease is likely to respond or is responsive to treatment with a therapeutic agent.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 23, 2023
    Applicant: CeMM - Forschungszentrum für Molekulare Medizin GmbH
    Inventors: Giulio SUPERTI-FURGA, Berend SNIJDER, Gregory VLADIMER
  • Patent number: 11486876
    Abstract: The invention relates to peripheral blood mononuclear cell (PBMC) monolayers or bone-marrow cell monolayers and methods for its culture and corresponding uses of said monolayers. The present invention also relates, in some aspects, to screening methods comprising the PBMC monolayer or bone-marrow cell monolayer of the invention for determination of response or lack of response of a disease to a therapeutic agent and/or drug screening methods. In some aspects, the invention further relates to methods for diagnosing a disease or predisposition to a disease in a PBMC donor or bone-marrow cell donor comprising the PBMCs/bone-marrow cells cultured according to the method of the invention and/or to methods for determining whether the disease is likely to respond or is responsive to treatment with a therapeutic agent.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: November 1, 2022
    Assignee: CeMM—Forschungszentrum für Molekulare Medizin GmbH
    Inventors: Giulio Superti-Furga, Berend Snijder, Gregory Vladimer
  • Patent number: 11434457
    Abstract: The invention relates to a multiwell imaging plate and a method for incubating non-adherent cells. The multiwell imaging plate includes multiple wells, at least some of the wells having a first chamber, a second chamber arranged on top of the first chamber, and a disturbance blocking structure provided between the first chamber and the second chamber. The first chamber is formed by one or more first sidewalls and a bottom wall while the second chamber is formed by one or more second sidewalls and includes an opening for introducing liquids. The disturbance blocking structure includes at least one through hole that provides a liquid connection between the first and second chambers.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: September 6, 2022
    Assignee: CEMM FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH
    Inventors: Nikolaus Krall, Gregory Vladimer, Berend Snijder
  • Publication number: 20190062685
    Abstract: The invention relates to a multiwell imaging plate and a method for incubating non-adherent cells. The multiwell imaging plate includes multiple wells, at least some of the wells having a first chamber, a second chamber arranged on top of the first chamber, and a disturbance blocking structure provided between the first chamber and the second chamber. The first chamber is formed by one or more first sidewalls and a bottom wall while the second chamber is formed by one or more second sidewalls and includes an opening for introducing liquids. The disturbance blocking structure includes at least one through hole that provides a liquid connection between the first and second chambers.
    Type: Application
    Filed: May 3, 2017
    Publication date: February 28, 2019
    Inventors: Nikolaus Krall, Gregory Vladimer, Berend Snijder
  • Publication number: 20170356911
    Abstract: The invention relates to peripheral blood mononuclear cell (PBMC) monolayers or bone-marrow cell monolayers and methods for its culture and corresponding uses of said monolayers. The present invention also relates, in some aspects, to screening methods comprising the PBMC monolayer or bone-marrow cell monolayer of the invention for determination of response or lack of response of a disease to a therapeutic agent and/or drug screening methods. In some aspects, the invention further relates to methods for diagnosing a disease or predisposition to a disease in a PBMC donor or bone-marrow cell donor comprising the PBMCs/bone-marrow cells cultured according to the method of the invention and/or to methods for determining whether the disease is likely to respond or is responsive to treatment with a therapeutic agent.
    Type: Application
    Filed: September 24, 2015
    Publication date: December 14, 2017
    Inventors: Giulio SUPERTI-FURGA, Berend SNIJDER, Gregory VLADIMER